Getting Started with the ExoDx Prostate Test

The ExoDx Prostate is a simple, non-invasive urine test that can discriminate the risk of aggressive  prostate cancer (defined as Gleason Score ≥7). This test is available as an At-Home Collection Kit that can be initiated by an electronic order signed by the physician and sent directly to the patient’s home for self-collection.

About the ExoDx Prostate Test

The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific antigen (PSA) 2-10ng/mL, or PSA in the “gray zone” who may be considering a biopsy. The ExoDx Prostate test provides a risk score that determines a patient’s potential risk of clinically significant prostate cancer (Gleason Score ≥7). The test is included in the National Comprehensive Cancer Network (NCCN) guidelines and has been clinically validated at the cut-point of 15.6 with a 91% sensitivity and 92% negative predictive value, meaning there is less than a 9% chance of having aggressive prostate cancer below the validated cut-point of 15.6.